Bachem stock eases as Swiss quote and revenue stay in view
Published on 09/04/2026 at 21:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Bachem stock (CH0012530207) closed at CHF 78.50 on September 3, 2026, after rising 2.28 percent on SIX Swiss Exchange volume of 276,527 shares. The move came as the latest market snapshot also put the share up 31.05 percent year to date.
Swiss trading stays liquid
Zonebourse showed the same September 3, 2026 close at CHF 78.50, while finanzen.ch reported an intraday move to CHF 77.40 at 4:28 PM on September 4, 2026. That leaves the stock within a narrow band of the recent range and gives investors a clear short-term reference point.
The latest market data also listed a market capitalization of about EUR 6.01 billion for the share class quoted in euros. A 31.05 percent gain since the start of the year is the kind of number that keeps a specialty pharma name on watchlists.
Latest report still matters
In the most recent figures available in the market data stream, Bachem was shown with revenue of CHF 1.17 billion and a net margin profile tied to a PER 2026 of 32.2x. The same source also pointed to PER 2027 of 25.1x, a concrete comparison that underlines how the valuation shifts over the next reporting year.
For investors, the key point is that the Swiss quote is trading against a company that is still measured by double-digit sales scale and a premium earnings multiple. That combination keeps the next operating update relevant even when the daily share move is modest.
Peptide supply remains the product angle
Bachem is a specialist in peptides and peptide-related chemistry, and that product base is what ties the share to the broader pharmaceutical supply chain. The market continues to price the business less like a general chemical name and more like a focused tools-and-services platform.
Share price and valuation
At September 3, 2026, the Bachem stock quote stood at CHF 78.50 on SIX Swiss Exchange, with the stock also described as trading at a market capitalization near EUR 6.01 billion. The same snapshot showed a year-to-date gain of 31.05 percent and a 2026 earnings multiple of 32.2x.
Bachem at a glance
- Company: Bachem Holding AG
- ISIN: CH0012530207
- Ticker: BANB
- Trading venue: SIX Swiss Exchange
- Price (as of September 3, 2026, 17:31): CHF 78.50
- Market capitalization: EUR 6.01 billion (as of September 3, 2026)
- Sector / Industry: Health Care / Pharmaceuticals
- Index membership: SPI
